Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells

Sara Carpi1, Beatrice Polini2, Giulio Poli3

  • 1Department of Pharmacy, University of Pisa, via Bonanno 6, 56126 Pisa, Italy. sara.carpi@unipi.it.

Marine Drugs
|May 19, 2018
PubMed

Insights

Euplotin C (EC) shows significant anti-melanoma activity, selectively killing cancer cells while sparing normal cells. This marine compound inhibits key pathways and targets the ryanodine receptor (RyR), offering a potential new treatment for melanoma.

Area of Science:

  • Marine Natural Products Chemistry
  • Cancer Biology
  • Pharmacology

Background:

  • Cutaneous melanoma is a severe skin cancer, necessitating the development of novel cytotoxic agents targeting new pathways.
  • Marine organisms are a rich source of unique bioactive compounds with therapeutic potential.

Purpose of the Study:

  • To evaluate the anti-melanoma activity of Euplotin C (EC), a metabolite from Euplotes crassus.
  • To elucidate the mechanism of action of EC in human cutaneous melanoma cells.
  • To investigate EC's potential as a novel anti-melanoma therapeutic scaffold.

Main Methods:

  • Cytotoxicity assays on human melanoma cell lines (A375, 501Mel, MeWo) and normal human dermal fibroblasts (HDFa).
  • Assessment of pro-apoptotic effects and cell migration inhibition.
  • Analysis of Erk and Akt pathway inhibition, and interaction with ryanodine receptors (RyR) using molecular modeling and antagonism studies with dantrolene.

Main Results:

  • EC demonstrated potent cytotoxicity against melanoma cells, with approximately 30-fold higher potency compared to non-cancer cells.
  • EC induced apoptosis and reduced melanoma cell migration.
  • EC inhibited Erk and Akt signaling pathways; its cytotoxicity was antagonized by dantrolene, suggesting RyR as a potential direct target.

Conclusions:

  • Euplotin C exhibits significant selective anti-melanoma activity.
  • EC's mechanism involves apoptosis induction, migration inhibition, and modulation of Erk/Akt pathways, potentially via ryanodine receptor interaction.
  • EC represents a promising new scaffold for developing selective RyR activators for melanoma and other cancer treatments.

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.9K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
87.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.2K
Overview Of Cell Separation And Isolation01:20

Overview Of Cell Separation And Isolation

Cell separation was first achieved in 1964 by S. H. Seal, who separated large tumor cells from the smaller blood cells using filtration. Two years later, Pohl and Hawk performed experiments on how cells respond differently to a nonuniform electric field based on the cell type. Such observations were the inception of cell separation methods, which allow isolating a single cell type from a heterogeneous sample.
7.7K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
23.1K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.7K